Search hospitals > Texas > Houston
The University of Texas Health Science Center at Houston
Claim this profileHouston, Texas 77030
Global Leader in Stroke
Global Leader in Unintentional Home Injuries
Conducts research for Coronavirus
Conducts research for Systemic Sclerosis
Conducts research for Hypertension
942 reported clinical trials
138 medical researchers
Summary
The University of Texas Health Science Center at Houston is a medical facility located in Houston, Texas. This center is recognized for care of Stroke, Unintentional Home Injuries, Coronavirus, Systemic Sclerosis, Hypertension and other specialties. The University of Texas Health Science Center at Houston is involved with conducting 942 clinical trials across 1,163 conditions. There are 138 research doctors associated with this hospital, such as Sean Savitz, Modupe Idowu, MD, Hope Northrup, and Jay-Jiguang Zhu, MD.Area of expertise
1Stroke
Global Leaderanticoagulant
48 hours
2Unintentional Home Injuries
Global LeaderTop PIs
Sean SavitzThe University of Texas Health Science Center at Houston3 years of reported clinical research
Expert in Stroke
Studies Ischemia
13 reported clinical trials
19 drugs studied
Modupe Idowu, MDUniversity of Texas Health Science Center at Houston5 years of reported clinical research
Studies Sickle Cell Disease
Studies Sickle Cell Anemia
10 reported clinical trials
10 drugs studied
Hope NorthrupMcGovern Medical School/Memorial Hermann Hospital3 years of reported clinical research
Studies Phenylketonuria
Studies Tuberous Sclerosis Complex
9 reported clinical trials
9 drugs studied
Jay-Jiguang Zhu, MDMemorial Hermann Texas Medical Center9 years of reported clinical research
Studies Brain Tumor
Studies Glioblastoma
8 reported clinical trials
32 drugs studied
Clinical Trials running at The University of Texas Health Science Center at Houston
Prostate Cancer
Epilepsy
Sickle Cell Disease
Frontotemporal Dementia
Unintentional Home Injuries
Coronavirus
Hemorrhagic Shock
Pulmonary Embolism
Atopic Dermatitis
Arteriovenous Fistula
Long-Term Safety of AAA617
for Prostate Cancer
The purpose of this post-marketing study is to further characterize the long-term outcome of known or potential risks of lutetium (177Lu) vipivotide tetraxetan also known as \[177Lu\]Lu-PSMA-617 or 177Lu-PSMA-617 and hereinafter referred to as AAA617. The study also seeks to further characterize (as possible) any other serious adverse reaction(s) in the long-term in adults with prostate cancer who received at least one dose of AAA617 from interventional, Phase I-IV Novartis sponsored clinical trials.
Recruiting3 awards Phase 4
MGC026
for Cancer
The study is designed to understand the safety, tolerability, pharmacokinetics, immunogenicity, and preliminary antitumor activity of MGC026 in participants with relapsed or refractory, unresectable, locally advanced or metastatic solid tumors The study has a dose escalation portion and a cohort expansion portion of the study. Participants will receive MGC026 by intravenous (IV) infusion. The dose of MGC026 will be assigned at the time of enrollment. Participants may receive up to 35 treatments if there are no severe side effects and as long as the cancer does not get worse. Participants will be monitored for side effects, and progression of cancer, have blood samples collected for routing laboratory work, and blood samples collected for research purposes.
Recruiting1 award Phase 1
Digital Health Coaching
for Cancer Survivorship
This study intends to explore feasibility, acceptability, and outcomes related to the use of a digital health coaching intervention for individuals who have completed primary therapy for cancer. Up to 625 individuals with diverse cancer diagnoses will be enrolled across up to 8 clinical sites to participate in a randomized wait-list control study. Those in the intervention group will receive 6 months of digital coaching up front followed by 6 months of ongoing monitoring via patient reported and clinical outcomes, as well as wearable data. Those in the control group will be monitored via patient reported and clinical outcomes as well as wearable data for the first 6 months followed by 6 months of digital health coaching. Both groups will collect fecal microbiome samples at enrollment and month 6. The study aims to explore if and how digital health coaching may be used to enhance outcomes for individuals following completion of primary cancer therapy.
Recruiting1 award N/A2 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at The University of Texas Health Science Center at Houston?
The University of Texas Health Science Center at Houston is a medical facility located in Houston, Texas. This center is recognized for care of Stroke, Unintentional Home Injuries, Coronavirus, Systemic Sclerosis, Hypertension and other specialties. The University of Texas Health Science Center at Houston is involved with conducting 942 clinical trials across 1,163 conditions. There are 138 research doctors associated with this hospital, such as Sean Savitz, Modupe Idowu, MD, Hope Northrup, and Jay-Jiguang Zhu, MD.
Where is The University of Texas Health Science Center at Houston located?
**The University of Texas Health Science Center at Houston**
- Located in the Texas Medical Center, close to Memorial Hermann - Texas Medical Center, Children's Memorial Hermann Hospital, and Harris Health System's Lyndon B. Johnson Hospital.
- Accessible by bus, with the Texas Medical Center Transit Center located nearby for convenient walking access to the campus.
Who should I call to ask about financial aid or insurance network?
**UTHealth Houston Employee Assistance Program (EAP):**
- Offers confidential assistance for personal and professional issues, including financial concerns.
- Contact: (713) 500-3327.
- Provides resources for students to manage educational expenses, including loans, scholarships, and financial aid.
**UT Health East Texas Charity Care Program:**
- Offers financial assistance to eligible uninsured patients.
- Requires completion of a financial assistance application and financial verification.
- Eligibility determined by a financial counselor may result in services at no charge or at a discounted amount.
**Texas Health Resources Financial Assistance Policy:**
- Provides care for individuals in need of financial assistance.
- Eligibility for assistance if income is less than or equal to 250% of the federal poverty guidelines.
- Assistance amount based on annual income, family size, and hospital bill balance.
What insurance does The University of Texas Health Science Center at Houston accept?
The University of Texas Health Science Center at Houston accepts the AcademicBlue/Blue Cross and Blue Shield of Texas PPO plan, covering inpatient hospitalization, outpatient doctor's visits, x-rays, and laboratory charges. All students are required to have health insurance as mandated by the University of Texas System. Students without personal health insurance can enroll in the student health insurance plan selected by the UT System.
What awards or recognition has The University of Texas Health Science Center at Houston received?
The University of Texas Health Science Center at Houston (UTHealth) is renowned for its exceptional neuroscience research, earning accolades at university, state, national, and international levels. It stands out as a leading global research university, committed to advancing health through innovative solutions. This is achieved through collaboration between basic scientists and clinical researchers across diverse disciplines.